Progesterone Only HRT for Perimenopause

If you are in perimenopause and exploring your hormone therapy options, you may have come across progesterone only HRT for perimenopause as a distinct and increasingly popular approach. Unlike combined HRT, which pairs estrogen with a progestogen, progesterone only therapy uses micronized progesterone on its own, without added estrogen. For women whose symptoms are primarily driven by low or fluctuating progesterone rather than estrogen, this can be a targeted and well-tolerated option. To understand the full hormone picture during this transition, start with The Complete Guide to Perimenopause.

In this article, we break down how progesterone only HRT works, what the evidence says, who it is best suited to, and how products like Utrogestan differ from synthetic progestins.

What Is Progesterone Only HRT for Perimenopause?

Progesterone only HRT for perimenopause involves taking micronized progesterone (most commonly branded as Utrogestan) without accompanying estrogen. It is distinct from combined HRT and is typically used in early perimenopause when estrogen levels are still adequate but progesterone is declining, causing symptoms like poor sleep, anxiety, and irregular cycles.

In the menstrual cycle, progesterone is produced primarily by the corpus luteum after ovulation. As perimenopause begins, ovulation becomes irregular, and progesterone output drops first, often well before estrogen follows suit. This progesterone deficit is frequently the root cause of early perimenopausal symptoms including sleep disruption, mood instability, heavier periods, and premenstrual tension that has worsened with age.

Progesterone only menopause therapy addresses this gap directly. Rather than introducing exogenous estrogen when estrogen levels may still be reasonable, it replenishes the hormone that is actually depleted. This makes it a logical first step for many women in early perimenopause.

"In early perimenopause, the primary hormonal change is often a fall in progesterone, not estrogen. Addressing that deficit first is both physiologically rational and clinically effective for a significant proportion of women."

Dr. Jerilynn Prior, MD, FRCPC, Professor of Endocrinology, University of British Columbia

What Is Utrogestan and How Does It Work?

Utrogestan is a licensed oral micronized progesterone capsule that contains body-identical progesterone, meaning it has the same molecular structure as the progesterone your ovaries produce. It is absorbed through the gut and metabolized into active neuroactive metabolites, including allopregnanolone, which has a calming effect on the brain via GABA receptors.

Utrogestan perimenopause prescriptions have grown significantly in recent years as clinical guidance has shifted toward body-identical hormones. It is available in 100 mg and 200 mg capsules and is typically taken orally at night, as its sedative-like properties make evening use particularly well suited to women experiencing sleep disruption.

It can also be used vaginally, which reduces some of the drowsiness associated with oral use while maintaining its uterine-protective effects. This route is sometimes preferred for women using Utrogestan as part of combined HRT to protect the uterine lining alongside estrogen.

Micronized progesterone HRT differs fundamentally from synthetic progestins (such as medroxyprogesterone acetate or norethisterone), which are structurally altered molecules that behave differently in the body and carry a different risk profile. Research published in Climacteric (2017) found that micronized progesterone does not appear to carry the same elevated breast cancer risk associated with synthetic progestins in combination HRT regimens.

Who Is Progesterone Only HRT Best Suited To?

Progesterone only HRT for perimenopause is most appropriate for women in early perimenopause who still have adequate estrogen levels but are experiencing symptoms driven by low progesterone, including sleep disturbance, worsened PMS, anxiety, and heavy or irregular periods. It may also suit women who prefer to avoid estrogen or who have certain estrogen-sensitive conditions.

Candidates who may benefit most include:

• Women aged 40 to 50 with irregular cycles and rising PMS-like symptoms
• Women with primarily sleep-based complaints linked to cycle changes
• Women with a history of estrogen sensitivity or fibrocystic breast tissue
• Women seeking a gentler introduction to hormone therapy before considering full combined HRT
• Women who have had a hysterectomy and only require progesterone for its own symptomatic effects

It is not typically used for women in later perimenopause or post-menopause whose estrogen levels have significantly declined, as estrogen replacement would be needed to address hot flashes, bone density loss, and genitourinary symptoms. For more on those concerns, see our article on Perimenopause and Vaginal Dryness Solutions.

How Does Progesterone Only HRT Affect Sleep and Mood?

Micronized progesterone HRT has a well-documented positive effect on sleep and mood in perimenopause. Its metabolite allopregnanolone acts on GABA-A receptors in the brain, producing anxiolytic and sedative effects similar to how benzodiazepines work, but through a natural hormonal pathway. This is why many women report significantly better sleep within days of starting Utrogestan.

Poor sleep is one of the most disruptive and under-treated symptoms of perimenopause, and it is frequently caused by declining progesterone rather than hot flashes alone. A study published in Menopause (2012) found that oral micronized progesterone taken at bedtime significantly improved sleep quality in perimenopausal and postmenopausal women, with participants reporting reduced time to sleep onset and fewer nighttime wakings.

Beyond sleep, the GABAergic action of progesterone metabolites contributes to a reduction in anxiety and irritability, which are common complaints during the hormonal flux of perimenopause. Women who describe feeling wired, restless, or on edge in the second half of their cycle often respond well to progesterone support. You can read more about why progesterone's calming role matters in our guide to Progesterone and Sleep: The Hidden Link.

"Oral micronized progesterone is unique among progestogens because of its neurosteroid metabolites. For women whose primary complaint is sleep disruption and anxiety during perimenopause, it can be genuinely transformative when prescribed appropriately."

Dr. Nick Panay, BBS, FRCOG, Consultant Gynaecologist and Past President, British Menopause Society

What Are the Risks and Side Effects of Progesterone Only Menopause Therapy?

Progesterone only HRT is generally well tolerated, but it does carry potential side effects, most commonly initial drowsiness, breast tenderness, bloating, and mood changes. These are often dose-dependent and tend to settle within the first few weeks. Serious risks are rare but should be discussed with a qualified prescriber before starting treatment.

The most common side effects women report when starting micronized progesterone HRT include:

• Drowsiness (usually when taken orally, which is why night-time dosing is recommended)
• Breast tenderness, particularly in the first cycle of use
• Spotting or changes to menstrual pattern as the body adjusts
• Mild bloating or digestive changes
• Mood dips in some women, though mood often improves overall

In terms of serious risks, data from the E3N cohort study (2019) found that use of progesterone only or combined therapy using micronized progesterone was not associated with a significant increase in breast cancer risk compared to HRT using synthetic progestins. This is a key distinction that many women and clinicians are not yet aware of.

As with any hormone therapy, it is important to have a full medical history review and regular monitoring. Utrogestan is a prescription medication and should not be self-administered without clinical oversight.

How Does Micronized Progesterone Differ From Synthetic Progestins?

Micronized progesterone is body-identical and structurally the same as the progesterone produced by the ovaries. Synthetic progestins, such as medroxyprogesterone acetate, are chemically altered forms that bind differently to receptors throughout the body. This difference in molecular structure leads to significant differences in safety profile, side effects, and how the body metabolizes them.

Key differences include:

• Breast tissue: Synthetic progestins are linked to increased breast cancer risk in combination HRT; micronized progesterone appears to carry a significantly lower risk
• Cardiovascular effects: Some synthetic progestins may counteract the cardiovascular benefits of estrogen; micronized progesterone does not appear to have this effect
• Mood and sleep: Micronized progesterone produces calming neuroactive metabolites; synthetic progestins do not
• Tolerability: Many women who experienced significant mood-related side effects on combined oral contraceptives (which contain synthetic progestins) tolerate micronized progesterone much better

This is why updated clinical guidelines in the UK and elsewhere now favour body-identical hormones where available, and why Utrogestan has become the most widely prescribed progestogen in British menopause care.

How Is Progesterone Only HRT Prescribed and Dosed?

Prescribing regimens for progesterone only HRT vary depending on whether a woman is perimenopausal or post-menopausal, and whether she has had a hysterectomy. Typical approaches in perimenopause include:

• Cyclical use: 200 mg taken orally for 12 to 14 days each month, often in the second half of the cycle, to mimic the natural luteal phase pattern and help regulate periods
• Continuous use: 100 mg taken nightly, often used when a woman has already reached menopause or is using it primarily for sleep and mood support
• Vaginal use: Typically 200 mg inserted vaginally, used to reduce systemic absorption when oral side effects are problematic

Dosing decisions should always be made with a healthcare professional experienced in menopause care. In the UK, this may be a GP, a menopause specialist, or a British Menopause Society-registered practitioner.